Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Zager, MD
Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikum Graz
Graz, Austria
- Universitair Ziekenhuis Leuven
Leuven, Belgium
- Centre Léon Bérard
Lyon, Rhône, France
- Charité Unversitätsmedizin Berlin Comprehensive Cancer Center
Berlin, Germany
- Universitätsklinikum Giessen Und Marburg
Marburg, Germany
- Universitätshautklinik Münster
Münster, Germany
- Universitätsklinikum Regensburg
Regensburg, Germany
- Universitätsklinikum Würzburg
Würzburg, Germany
- Istituto Europeo Di Oncologia
Milan, Italy
- Clínic Barcelona
Barcelona, Spain
- Hospital Ramón Y Cajal
Madrid, Spain
- Universitätsspital Zürich
Zurich, Switzerland
- University Hospital Southampton Nhs Trust
Southampton, Hampshire, United Kingdom
- Aintree University Hospital
Liverpool, United Kingdom
- University of Arizona
Tucson, Arizona, United States
- Stanford University
Palo Alto, California, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Ohio State University James Cancer Center
Columbus, Ohio, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University of Tennessee Health Science Center
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2016
- Primary completion
- 18 May 2023
- Completion
- 15 Aug 2023
- Last update posted
- 21 Dec 2023
- Registered enrollment
- 102
- Registry id
- NCT02678572
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.